article thumbnail

Guide to using AAV vectors in gene therapy

Drug Discovery World

This is largely due to their highly stable Inverted Terminal Repeat (ITR) regions, as this secondary structure is prone to deletions during propagation in bacteria and cannot be read by standard Sanger sequencing. Dr O’Hara also provided an AAV plasmid preparation case study. Why are those important?

article thumbnail

Guide to using AAV vectors in gene therapy

Drug Discovery World

This is largely due to their highly stable Inverted Terminal Repeat (ITR) regions, as this secondary structure is prone to deletions during propagation in bacteria and cannot be read by standard Sanger sequencing. Dr O’Hara also provided an AAV plasmid preparation case study. Why are those important?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Advantages and Challenges of Next Generation Sequencing in Food Safety Testing

XTalks

As the leader in genomic sequencing, Clear Labs helps its clients better understand and manage pathogens, from foodborne illnesses to SARS-CoV2. Salmonella , for example, has more than 2,400 types of the bacteria. Xtalks spoke to Sasan Amini, founder and CEO of Clear Labs, to find out more about the evolving food safety standards. .

article thumbnail

Advances in cell line development

Drug Discovery World

For instance, bacteria and yeast cell lines are easier to cultivate compared with mammalian cell lines, requiring less maintenance for the medium they are grown in. Recent years have also seen the development of technologies that enable a better genomic and transcriptomic analysis of single cells.

article thumbnail

Improving quality control for CAR T cell therapies

Drug Discovery World

The immune system typically identifies foreign entities such as bacteria and viruses and activates lymphocytes such as T cells to destroy them with overwhelming force. If the gene does not integrate into the genome, the cell will not become a CAR T cell. National Institutes of Health researcher Ping Jin, Ph.D.